| 02/2012 |
Vivus Inc. Public Offering of Common Stock Advisor |
$202,500,000 |
Details
$202,500,000
Public Offering of Common Stock
Advisor
February 2012
|
| 02/2012 |
Algeta Private Placement of Common Stock Advisor |
NOK 260,000,000 |
Details
NOK 260,000,000
Private Placement of Common Stock
Advisor
February 2012
|
| 12/2011 |
Cell Therapeutics Private Placement of Preferred Stock and Warrants Advisor |
$20,000,000 |
Details
$20,000,000
Private Placement of Preferred Stock and Warrants
Advisor
December 2011
|
| 08/2011 |
Vivus Inc. Registered Direct Placement of Common Stock Advisor |
$45,800,000 |
Details
$45,800,000
Registered Direct Placement of Common Stock
Advisor
August 2011
|
| 07/2011 |
Genetic Technologies, Inc. Private Placement of Common Stock US Placement Agent |
A$11,700,000 |
Details
A$11,700,000
Private Placement of Common Stock
US Placement Agent
July 2011
|
| 06/2011 |
Cell Therapeutics Private Placement of Preferred Stock and Warrants Financial Advisor |
$30,000,000 |
Details
$30,000,000
Private Placement of Preferred Stock and Warrants
Financial Advisor
June 2011
|
| 06/2011 |
Pharmacyclics, Inc. Registered Direct Placement of Common Stock Advisor |
$57,100,000 |
Details
$57,100,000
Registered Direct Placement of Common Stock
Advisor
June 2011
|
| 04/2011 |
Inhibitex, Inc. Public Offering of Common Stock Financial Advisor |
$54,000,000 |
Details
$54,000,000
Public Offering of Common Stock
Financial Advisor
April 2011
|
| 03/2011 |
BioSante Pharmaceuticals Registered Direct Placement of Common Stock Financial Advisor |
$25,100,000 |
Details
$25,100,000
Registered Direct Placement of Common Stock
Financial Advisor
March 2011
|
| 02/2011 |
4SC AG Capital Increase Advisor |
€11,740,000 |
Details
€11,740,000
Capital Increase
Advisor
February 2011
|
| 01/2011 |
Amarin Corp. Public Offering of American Depositary Shares Advisor |
$104,900,000 |
Details
$104,900,000
Public Offering of American Depositary Shares
Advisor
January 2011
|
| 12/2010 |
BioSante Pharmaceuticals Registered Direct Placement of Common Stock and Warrants Financial Advisor |
$18,000,000 |
Details
$18,000,000
Registered Direct Placement of Common Stock and Warrants
Financial Advisor
December 2010
|
| 12/2010 |
Neurologix, Inc. Secured Notes Co-Placement Agent |
$7,000,000 |
Details
$7,000,000
Secured Notes
Co-Placement Agent
December 2010
|
| 11/2010 |
GeneGo, Inc. Company Sale Sole Financial Advisor |
Undisclosed |
Details
Undisclosed
Company Sale
Sole Financial Advisor
November 2010
|
| 11/2010 |
Avanir Pharmaceuticals Public Offering of Common Stock Financial Advisor |
$83,200,000 |
Details
$83,200,000
Public Offering of Common Stock
Financial Advisor
November 2010
|
| 10/2010 |
Cell Therapeutics Private Placement of Preferred Stock and Warrants Financial Advisor |
$21,000,000 |
Details
$21,000,000
Private Placement of Preferred Stock and Warrants
Financial Advisor
October 2010
|
| 08/2010 |
Intendis GmbH (Bayer HealthCare) Product Licensing Advisor |
Undisclosed |
Details
Undisclosed
Product Licensing
Advisor
August 2010
|
| 07/2010 |
Response Biomedical Corp. Private Placement of Common Stock Placement Agent |
C$8,000,000 |
Details
C$8,000,000
Private Placement of Common Stock
Placement Agent
July 2010
|
| 06/2010 |
BioSante Pharmaceuticals Registered Direct Placement of Common Stock Financial Advisor |
$15,000,000 |
Details
$15,000,000
Registered Direct Placement of Common Stock
Financial Advisor
June 2010
|
| 06/2010 |
Pharmacyclics, Inc. Registered Direct Placement of Common Stock Advisor |
$52,000,000 |
Details
$52,000,000
Registered Direct Placement of Common Stock
Advisor
June 2010
|
| 04/2010 |
Genetic Technologies Group Private Placement of Common Stock Placement Agent |
$1,089,681 |
Details
$1,089,681
Private Placement of Common Stock
Placement Agent
April 2010
|
| 03/2010 |
Cell Therapeutics Private Placement of Preferred Stock and Warrants Financial Advisor |
$20,000,000 |
Details
$20,000,000
Private Placement of Preferred Stock and Warrants
Financial Advisor
March 2010
|
| 03/2010 |
Epigenomics AG Rights Offering of Common Stock US Placement Agent |
€33,100,000 |
Details
€33,100,000
Rights Offering of Common Stock
US Placement Agent
March 2010
|
| 01/2010 |
Cell Therapeutics Private Placement of Preferred Stock and Warrants Advisor |
$30,000,000 |
Details
$30,000,000
Private Placement of Preferred Stock and Warrants
Advisor
January 2010
|
| 09/2009 |
Vivus Inc. Public Offering of Common Stock Advisor |
$108,675,000 |
Details
$108,675,000
Public Offering of Common Stock
Advisor
September 2009
|
| 09/2009 |
Intendis GmbH (Bayer HealthCare) Product Acquistion Advisor |
Undisclosed |
Details
Undisclosed
Product Acquistion
Advisor
September 2009
|
| 08/2009 |
Avanir Pharmaceuticals Controlled Equity Offering Sub-Sales Agent |
$10,530,000 |
Details
$10,530,000
Controlled Equity Offering
Sub-Sales Agent
August 2009
|
| 08/2009 |
Pharmacyclics, Inc. Rights Offering of Common Stock Financial Advisor |
$28,800,000 |
Details
$28,800,000
Rights Offering of Common Stock
Financial Advisor
August 2009
|
| 07/2009 |
Cell Therapeutics Public Offering of Common Stock and Warrants Financial Advisor |
$43,851,499 |
Details
$43,851,499
Public Offering of Common Stock and Warrants
Financial Advisor
July 2009
|
| 05/2009 |
Response Biomedical Corp. Unit Offering US Placement Agent |
C$11,000,000 |
Details
C$11,000,000
Unit Offering
US Placement Agent
May 2009
|
| 02/2009 |
Epigenomics AG Capital Increase Financial Advisor |
€5,182,000 |
Details
€5,182,000
Capital Increase
Financial Advisor
February 2009
|
| 02/2009 |
Pharmasset, Inc. Registered Direct Placement of Common Stock Financial Advisor |
$45,500,000 |
Details
$45,500,000
Registered Direct Placement of Common Stock
Financial Advisor
February 2009
|
| 08/2008 |
Vivus Inc. Registered Direct Placement of Common Stock Placement Agent |
$65,000,000 |
Details
$65,000,000
Registered Direct Placement of Common Stock
Placement Agent
August 2008
|
| 07/2008 |
Pharmasset, Inc. Registered Direct Placement of Common Stock Financial Advisor |
$25,900,000 |
Details
$25,900,000
Registered Direct Placement of Common Stock
Financial Advisor
July 2008
|
| 02/2008 |
Epigenomics AG Rights Offering of Common Stock Placement Agent |
€13,500,000 |
Details
€13,500,000
Rights Offering of Common Stock
Placement Agent
February 2008
|
| 11/2007 |
Pharmaxis, Inc. Private Placement of Common Stock Financial Advisor |
A$20,000,000 |
Details
A$20,000,000
Private Placement of Common Stock
Financial Advisor
November 2007
|
| 10/2007 |
DUSA Pharmaceuticals, Inc. Private Placement of Common Stock and Warrants Financial Advisor |
$11,000,000 |
Details
$11,000,000
Private Placement of Common Stock and Warrants
Financial Advisor
October 2007
|
| 08/2007 |
Encysive Pharmaceuticals Private Placement of Common Stock Co-Placement Agent |
$15,000,000 |
Details
$15,000,000
Private Placement of Common Stock
Co-Placement Agent
August 2007
|
| 06/2007 |
IDM Pharma Registered Direct Placement of Common Stock and Warrants Financial Advisor |
$25,000,000 |
Details
$25,000,000
Registered Direct Placement of Common Stock and Warrants
Financial Advisor
June 2007
|
| 05/2007 |
Vasogen Inc. Private Placement of Common Stock and Warrants Financial Advisor |
$16,000,000 |
Details
$16,000,000
Private Placement of Common Stock and Warrants
Financial Advisor
May 2007
|
| 05/2007 |
Avalon Pharmaceuticals Private Placement of Common Stock Co-Placement Agent |
$20,000,000 |
Details
$20,000,000
Private Placement of Common Stock
Co-Placement Agent
May 2007
|
| 05/2007 |
Epigenomics AG Private Placement of Common Stock Placement Agent |
$6,600,000 |
Details
$6,600,000
Private Placement of Common Stock
Placement Agent
May 2007
|
| 01/2007 |
Avalon Pharmaceuticals Private Placement of Common Stock Financial Advisor |
$10,000,000 |
Details
$10,000,000
Private Placement of Common Stock
Financial Advisor
January 2007
|